Skip to main content

Peer Review reports

From: FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine

Original Submission
12 Aug 2015 Submitted Original manuscript
21 Aug 2015 Reviewed Reviewer Report - Sebastian Krug
2 Sep 2015 Reviewed Reviewer Report - Motoyoshi Tanaka
3 Sep 2015 Reviewed Reviewer Report - Sven Lang
6 Oct 2015 Author responded Author comments - Dannel Yeo
Resubmission - Version 2
6 Oct 2015 Submitted Manuscript version 2
10 Oct 2015 Reviewed Reviewer Report - Motoyoshi Tanaka
16 Oct 2015 Reviewed Reviewer Report - Sebastian Krug
24 Oct 2015 Reviewed Reviewer Report - Sven Lang
24 Dec 2015 Author responded Author comments - Dannel Yeo
Resubmission - Version 3
24 Dec 2015 Submitted Manuscript version 3
Publishing
8 Jan 2016 Editorially accepted
16 Jan 2016 Article published 10.1186/s12885-016-2057-z

You can find further information about peer review here.

Back to article page